Celltrion operating profit more than doubled last year, driven by Europe, US sales

Celltrion's operating profit rose 109% to KRW 522 billion (USD 486 million) last year as sales increased in Europe and the US, according to filings to the Korea Exchange.

The US Food and Drug Administration will likely release its report on Celltrion's Incheon plant in March or April, DailyPharm reported, without citing anyone.